Their accounts come as sellers of unapproved 'research use only' peptides may soon be allowed to stop printing that warning on their products.
Recap by typeshit. Full story at CNN on MSN.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
USA TODAY covers the copycat GLP-1 crackdown, from the Apothecary Pharma recall to an import alert on a Chengdu factory. Novo says it has filed over 130 lawsuits.
A fitness coach says clients on GLP-1 drugs often focus on how fast weight drops instead of whether they eat enough protein.
She points to women getting pregnant unexpectedly after GLP-1s restore ovulation, and questions the mixed messages women get about these drugs and fertility.
The Business Research Company credits oral peptides, personalized obesity care and wider reimbursement for the projected growth. A promotional forecast.
Covers the 28.3% versus 25.0% weight loss figures, the 12% who quit at 9 mg in TRIUMPH-2, and why online vials sold as Reta aren't the trial drug.
Loading…